JOURNAL OF CHEMICAL RESEARCH 2016 447
Using this procedure, a simple ether extraction is used to isolate
the pure product.
5-Methyl-4-pentyl-3-tosylthiazolidine-2-thione (3d)
The crude product was purified by washing with cold ether affording
0
.28 g (78%) 3d. Yellow oil; IR: n 2980, 2954, 1648, 1590, 1463, 1325,
Experimental
All chemicals used in this work except the aziridines were purchased
from Merck and were used without further purification. We prepared
–1 1 3
1
244, 1120 cm ; H NMR: δ 0.94 (t, J = 6.8 Hz, Me), 1.32–1.47 (m, 3 CH ),
2
3
1.53 (d, J = 6.5 Hz, Me), 1.78–1.82 (m, CH ), 2.34 (s, Me), 3.79–3.84 (m,
2
3
3
CH), 4.84–4.88 (m, CH), 7.41 (d, J = 6.9 Hz, 2 CH), 7.84 (d, J = 6.7 Hz,
2 CH); C NMR: δ 13.2 (Me), 15.0 (Me), 19.5 (CH ), 20.4 (CH ), 23.4
(Me), 28.2 (CH ), 33.5 (CH ), 51.0 (CH), 68.3 (CH ), 128.3 (2 CH), 130.7
(2 CH), 135.2 (C), 143.4 (C), 197.5 (C); EI-MS (70 eV): m/z (%) 357 (M , 1),
171 (43), 155 (100), 112 (73), 91 (61), 43 (31). Anal. calcd for C H NO S
(357.55): C, 53.75, H, 6.48; N, 3.92, S, 26.90; found: C, 53.89, H, 6.64; N,
4.11, S, 26.93%.
2
0
13
N-tosylaziridines using the literature procedures. Melting points were
measured on an Electrothermal 9100 apparatus. Elemental analyses for
C, H, and N were performed using a Heraeus CHN-O-Rapid analyser.
Mass spectra were recorded on a Finnigan-MAT 8430 spectrometer
operating at an ionisation potential of 70 eV. IR spectra were measured
on a Shimadzu IR-460 spectrometer (the samples were dissolved in
2
2
2
2
2
+
16
23
2 3
1
13
CHCl ). H NMR and C NMR spectra were measured with a Bruker
3
4
-Hexyl-3-tosylthiazolidine-2-thione (3e)
The crude product was purified by re-crystallisation from ether affording
.31 g (87%) 3e. M.p. 77–80 °C; IR: n 3023, 2984, 2963, 1652, 1585, 1457,
DRX-500 Avance spectrometer at 500.1 and 125.8 MHz, respectively.
NMR spectra were obtained for solutions in CDCl using TMS as the
internal standard. Chemical shifts (δ) are given in ppm and coupling
constants (J) are given in Hz.
3
0
–1
1
3
1322, 1278, 1117 cm ; H NMR: δ 0.93 (t, J = 6.4 Hz, Me), 1.30–1.45 (m,
4
CH ), 1.83–1.86 (m, CH ), 2.37 (s, Me), 3.22–3.36 (m, CH ), 4.91–4.94
2
2
2
Synthesis of compounds 4; general procedure
3
3
13
(m, CH), 7.40 (d, J = 6.6 Hz, 2 CH), 7.82 (d, J = 6.9 Hz, 2 CH); C NMR:
A mixture of 2-pyridinecarboxaldehyde oxime (20 mol%, 24 mg) and
δ 13.6 (Me), 21.4 (CH ), 22.7 (CH ), 23.5 (Me), 29.2 (CH ), 31.1 (CH ), 33.8
2
2
2
2
CS or a thicyanate (1–2 mmol) in DMF (3 mL) was heated to 40 °C.
(CH ), 36.1 (CH ), 70.1 (CH), 128.9 (2 CH), 130.2 (2 CH), 135.6 (C), 143.2
2 2
2
+
Aziridine (1 mmol) was then added to the resulting mixture in one
portion. The reaction mixture was then stirred for 4–7 h at 40 °C until
(C), 198.2 (C); EI-MS (70 eV): m/z (%) 357 (M , 1), 171 (51), 155 (100), 112
(76), 91 (44). Anal. calcd for C H NO S (357.55): C, 53.75, H, 6.48; N,
16
23
2 3
the substrate disappeared. Afterwards, the mixture was poured in H O
3.92, S, 26.90; found: C, 53.79, H, 6.56; N, 3.99, S, 26.98%.
-Phenyl-3-tosylthiazolidine-2-thione (3f)
The crude product was purified by recrystallisation from ether affording
2
(5 mL) and the pH was adjusted to 3 by addition of concentrated HCl.
5
The mixture was extracted with EtOAc (3 × 6 mL). The organic layers
were combined, dried over MgSO , filtered, and concentrated in vacuo
4
0
.34 g (98%) 3f. M.p. 116–118 °C; IR: n 3012, 2988, 2973, 1662, 1590,
to give crude products. If solid, the crude product was further purified
by recrystallisation from ether. The catalyst could be recovered for
another run by recrystallisation from EtOH–CH Cl .
–1 1
1448, 1319, 1283, 1109 cm ; H NMR: δ 2.36 (s, Me), 4.64–4.69 (m, CH),
3
1
3
4.81–4.87 (m, CH ), 7.18–7.42 (m, 7 CH), 7.82 (d, J = 7.1, 2 CH); C NMR:
2
2
2
δ 21.7 (Me), 62.5 (CH), 68.5 (CH ), 127.7 (CH), 128.8 (2 CH), 129.2 (2 CH),
2
4
-Benzyl-3-tosylthiazolidine-2-thione (3a)
The crude product was purified by recrystallisation from ether affording
.35 g (94%) 3a. M.p. 86–88.5 °C; IR: n 3017, 2987, 1629, 1589, 1465,
1
30.3 (2 CH), 130.7 (2 CH), 136.7 (C), 139.4 (C), 146.6 (C), 198.1 (C); EI-
+
MS (70 eV): m/z (%) 349 (M , 6), 171 (49), 155 (80), 104 (63), 91 (56), 77
0
(100), 54 (36). Anal. calcd for C H NO S (349.49): C, 54.99, H, 4.33; N,
16
15
2 3
–1 1
1
248, 1309, 1148 cm ; H NMR: δ 2.38 (s, Me), 2.92 (m, CH), 3.10 (dd,
4.01, S, 27.52; found: C, 55.11, H, 4.48, N, 4.18, S, 27.51%.
2
3
2
3
J = 6.9 Hz, J = 7.2 Hz, CH), 3.30 (dd, J = 7.1 Hz, J = 4.6 Hz, CH), 3.45
2
3
3
4-Methyl-5-phenyl-3-tosylthiazolidine-2-thione (3g)
(dd, J = 7.1 Hz, J = 12.1 Hz, CH), 4.93–4.99 (m, CH), 7.11 (t, J = 6.0 Hz,
3
3
The crude product was purified by recrystallisation from ether
affording 0.32 g (87%) 3g. M.p. 93–95 °C; IR: n 3028, 2976,
CH), 7.17 (d, J = 6.8 Hz, 2 CH), 7.24–7.37 (m, 4 CH), 7.82 (d, J = 7.0 Hz, 2
13
CH); C NMR: δ 23.1 (Me), 34.9 (CH ), 39.4 (CH ), 67.8 (CH), 127.0 (CH),
2
2
–
1
1
2
960, 1653, 1587, 1456, 1330, 1276, 1124 cm ; H NMR: δ 1.17 (d,
128.9 (2 CH), 129.2 (2 CH), 129.5 (2 CH), 130.1 (2 CH), 135.6 (C), 138.9
3
3
+
J = 6.1, Me), 2.35 (s, Me), 4.32–4.39 (m, CH), 4.67 (d, J = 6.7, CH),
(
1
C), 143.6 (C), 198.2 (C); EI-MS (70 eV): m/z (%) 363 (M , 3), 171 (63),
55 (34), 91 (100), 77 (52), 43 (44), 34 (18). Anal. calcd for C H NO S
3
13
7
2
.14–7.40 (m, 7 CH), 7.81 (d, J = 6.5, 2 CH); C NMR: δ 14.2 (Me),
3.5 (Me), 57.1 (CH), 62.4 (CH), 125.0 (CH), 128.1 (2 CH), 128.9 (2
CH), 129.1 (2 CH), 130.3 (2 CH), 134.3 (C), 137.1 (C), 143.8 (C), 197.7
17
17
2 3
(363.52): C, 56.17, H, 4.71; N, 3.85, S, 26.46; found: C, 56.43, H, 4.93; N,
3.95, S, 26.43%.
+
(
C); EI-MS (70 eV): m/z (%) 363 (M , 5), 171 (44), 155 (79), 118 (67),
4
-Methyl-4-propyl-3-tosylthiazolidine-2-thione (3b)
The crude product was purified by recrystallisation from ether affording
.29 g (89%) 3b. Yellow oil; IR: n 2983, 2970, 1634, 1594, 1473, 1236, 1324,
9
1 (51), 77 (100). Anal. calcd for C H NO S (363.52): C, 56.17, H,
17 17 2 3
4.71, N, 3.85, S, 26.46; found: C, 56.23, H, 4.79; N, 3.87, S, 26.52%.
0
–1
1
3
Methyl 5-phenyl-2-thioxo-3-tosylthiazolidine-4-carboxylate (3h)
1
132 cm ; H NMR: δ 0.96 (t, J = 6.4 Hz, Me), 1.28 (s, Me), 1.32–1.49 (m,
3
CH CH ), 2.36 (s, Me), 3.31–3.46 (m, CH ), 7.43 (d, J = 6.9 Hz, 2 CH), 7.82
The crude product was purified by recrystallisation from ether affording
2
3
2
2
13
(
d, J = 6.7 Hz, 2 CH); C NMR: δ 15.8 (Me), 16.0 (CH ), 20.1 (Me), 23.7
0.36 g (89%) 3h. M.p. 105–107 °C; IR: n 3031, 2973, 1743, 1652, 1590,
2
–1 1
(Me), 40.4 (CH ), 45.6 (CH ), 78.2 (C), 129.6 (2 CH), 130.5 (2 CH), 134.6
1461, 1327, 1260, 1128 cm ; H NMR: δ 2.36 (s, Me), 3.59 (s, MeO), 4.89
3 3 3
2
2
+
(
1
C), 143.8 (C), 197.9 (C); EI-MS (70 eV): m/z (%) 329 (M , 2), 253 (28),
71 (41), 131 (78), 91 (42), 98 (100), 43 (47). Anal. calcd for C H NO S
2 3
(d, J = 10.9, CH), 5.19 (d, J = 10.8, CH), 7.16 (d, J = 6.8, CH), 7.22 (d,
3
3
13
J = 6.6, 2 CH), 7.27–7.41 (m, 4 CH), 7.82 (d, J = 6.9, 2 CH); C NMR: δ
14
19
(329.50): C, 51.03, H, 5.81; N, 4.25, S, 29.19; found: C, 51.14, H, 5.97; N,
23.4 (Me), 54.6 (MeO), 56.4 (CH), 70.2 (CH), 127.3 (CH), 128.2 (2 CH),
4
.42, S, 29.36%.
128.6 (2 CH), 128.9 (2 CH), 130.9 (2 CH), 134.5 (C), 139.5 (C), 144.1
+
(C), 169.2 (C), 198.1 (C); EI-MS (70 eV): m/z (%) 407 (M , 7), 171 (51),
4
-Butyl-3-tosylthiazolidine-2-thione (3c)
The crude product was purified by recrystallisation from ether affording
.28 g (85%) 3c. M.p. 72–73 °C; IR: n 2980, 2954, 1648, 1590, 1463,
1
62 (68), 155 (71), 78 (46), 77 (100), 54 (28). Anal. calcd for C H NO S
18 17 4 3
(407.53): C, 53.05, H, 4.20; N, 3.44, S, 23.60; found: C, 53.11, H, 4.29; N,
0
3.42, S, 23.61%.
–1
1
3
1
245, 1320, 1122 cm ; H NMR: δ 0.98 (t, J = 6.4 Hz, Me), 1.39–1.50
2
Hexahydro-3-tosyl[1,3]benzothiazole-2(3H)-thione (3i)
(
m, CH CH ), 1.85–1.92 (m, CH ), 2.34 (s, Me), 3.26 (dd, J = 7.3 Hz,
2
2
2
3
2
3
J = 6.7 Hz, CH), 3.37 (dd, J = 6.3 Hz, J = 11.7 Hz, CH), 4.87 (m, CH), 7.40
The crude product was purified by recrystallisation from ether affording
3
3
13
(
2
d, J = 6.9 Hz, 2 CH), 7.81 (d, J = 6.7 Hz, 2 CH); C NMR: δ 15.6 (Me),
0.32 g (98%) 3i. M.p. 181–182 °C; IR: n 3020, 2964, 1645, 1579, 1449, 1313,
–1 1
2.0 (CH ), 23.5 (Me), 28.4 (CH ), 30.0 (CH ), 34.2 (CH ), 78.0 (CH ),
1268, 1121 cm ; H NMR: δ 1.42–2.19 (m, 8 H), 2.34 (s, Me), 3.14–3.22 (m,
3 3
2
2
2
2
2
128.2 (2 CH), 130.3 (2 CH), 136.0 (C), 142.9 (C), 198.2 (C); EI-MS (70 eV):
CH), 4.01–4.05 (m, CH), 7.40 (d, J = 6.7, 2 CH), 7.84 (d, J = 6.9, 2 CH);
+
13
m/z (%) 329 (M , 6), 171 (34), 155 (78), 133 (57), 99 (100), 43 (40). Anal.
C NMR: δ 21.9 (CH ), 23.4 (Me), 26.2 (CH ), 27.8 (CH ), 32.1 (CH ), 53.5
2
2
2
2
calcd for C H NO S (329.50): C, 51.03, H, 5.81; N, 4.25, S, 29.19; found:
C, 51.18, H, 5.97; N, 4.38, S, 29.22%.
(CH), 68.1 (CH), 128.4 (2 CH), 130.0 (2 CH), 135.1 (C), 143.9 (C), 198.9
(C); EI-MS (70 eV): m/z (%) 327 (M , 7), 171 (58), 155 (100), 91 (64), 82
14
19
2 3
+